UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment

June 27 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.